Cyclosporine Completed Phase 2 Trials for Hematologic Diseases / Myelodysplastic Syndromes (MDS) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00001839A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome